Skip to main content
Oxidative Medicine and Cellular Longevity logoLink to Oxidative Medicine and Cellular Longevity
. 2026 Jul 29;2026:9782363. doi: 10.1155/omcl/9782363

Correction to “Ginsenoside Rb1 Treatment Attenuates Pulmonary Inflammatory Cytokine Release and Tissue Injury Following Intestinal Ischemia Reperfusion Injury in Mice”

PMCID: PMC13417721  PMID: 42522789

Y. Jiang, Z. Zhou, Q. Meng, et al., “Ginsenoside Rb1 Treatment Attenuates Pulmonary Inflammatory Cytokine Release and Tissue Injury Following Intestinal Ischemia Reperfusion Injury in Mice,” Oxidative Medicine and Cellular Longevity, 2015, 843721, https://doi.org/10.1155/2015/843721.

In the article, it was reported on PubPeer [1] that Figure 2a appears to be a zoomed‐out image taken from Figure 1a of a previous publication of many of the authors [2], cited in the article as reference 32. The authors wish to clarify that both studies were conducted concurrently as part of a larger research program, and that Sham control animals were shared between the two studies. A revised Figure 2 legend is as follows, which acknowledges the above.

Intestinal histologic evaluation in the groups. ((a)–(h)) Histopathologic changes of the small‐intestinal mucosa were observed under light microscopy (hematoxylin and eosin, ×200). (a) Sham group. The representative image was previously published in Ref. [32]. The two studies were conducted concurrently as part of a larger research program and shared the same Sham control animals, with each study focusing on a different target organ (kidney and lung, respectively). (b) II/R group, (c) II/R + NS group, (d) II/R + Rb1‐30 group, (e) II/R + Rb1‐60 group, (f) ATRA + Sham group, (g) ATRA + II/R group, and (h) ATRA + II/R + Rb1‐60 group. Data are mean ± SD, n = 10;   p < 0.05 versus Sham group, # p < 0.05 versus II/R group, and $ p < 0.05 versus II/R + Rb1‐60 group.

We apologize for this error.

References


Articles from Oxidative Medicine and Cellular Longevity are provided here courtesy of Wiley

RESOURCES